NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host–Gut Microbiota Interactions during Inflammatory Bowel Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host–Gut Microbiota Interactions during Inflammatory Bowel Disease
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-02-26
DOI
10.3389/fimmu.2018.00363
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation During Aging in Mice by Altering the Intestinal Microbiota
- (2017) Alicia S. Wellman et al. GASTROENTEROLOGY
- NAD metabolism fuels human and mouse intestinal inflammation
- (2017) Romana R Gerner et al. GUT
- NLRX1 Regulates Effector and Metabolic Functions of CD4+T Cells
- (2017) Andrew Leber et al. JOURNAL OF IMMUNOLOGY
- Translating nutritional immunology into drug development for inflammatory bowel disease
- (2016) Andrew Leber et al. CURRENT OPINION IN GASTROENTEROLOGY
- The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
- (2016) Martin Kummen et al. GUT
- Immunometabolism and autoimmunity
- (2016) Jenny Freitag et al. IMMUNOLOGY AND CELL BIOLOGY
- Glutamine promotes intestinal SIgA secretion through intestinal microbiota and IL-13
- (2016) Miaomiao Wu et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Organoids as an in vitro model of human development and disease
- (2016) Aliya Fatehullah et al. NATURE CELL BIOLOGY
- NLRX1 Acts as an Epithelial-Intrinsic Tumor Suppressor through the Modulation of TNF-Mediated Proliferation
- (2016) Ivan Tattoli et al. Cell Reports
- The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals
- (2016) A. Alicia Koblansky et al. Cell Reports
- Energy metabolism in intestinal epithelial cells during maturation along the crypt-villus axis
- (2016) Huansheng Yang et al. Scientific Reports
- Microbiota-Mediated Inflammation and Antimicrobial Defense in the Intestine
- (2015) Silvia Caballero et al. Annual Review of Immunology
- Human Enteroids/Colonoids and Intestinal Organoids Functionally Recapitulate Normal Intestinal Physiology and Pathophysiology
- (2015) Nicholas C. Zachos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolic and Microbial Modulation of the Large Intestine Ecosystem by Non-Absorbed Diet Phenolic Compounds: A Review
- (2015) Juana Mosele et al. MOLECULES
- Oral supplementation with l-glutamine alters gut microbiota of obese and overweight adults: A pilot study
- (2015) Alessandra Zanin Zambom de Souza et al. NUTRITION
- Systems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile Infection
- (2015) Andrew Leber et al. PLoS One
- Clostridium difficile infection and inflammatory bowel disease
- (2015) Camelia Cojocariu et al. Turkish Journal of Gastroenterology
- Modeling the Regulatory Mechanisms by Which NLRX1 Modulates Innate Immune Responses to Helicobacter pylori Infection
- (2015) Casandra W. Philipson et al. PLoS One
- Modeling-Enabled Characterization of Novel NLRX1 Ligands
- (2015) Pinyi Lu et al. PLoS One
- IBD: Microbiota Manipulation through Diet and Modified Bacteria
- (2014) Hannah L. Simpson et al. DIGESTIVE DISEASES
- Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation
- (2014) Mako Nakaya et al. IMMUNITY
- Emerging Significance of NLRs in Inflammatory Bowel Disease
- (2014) Beckley K. Davis et al. INFLAMMATORY BOWEL DISEASES
- Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut
- (2014) R Caruso et al. Mucosal Immunology
- Treatment of inflammatory bowel disease (IBD)
- (2014) Anand B. Pithadia et al. Pharmacological Reports
- The gut microbiota and inflammatory bowel disease
- (2014) Katsuyoshi Matsuoka et al. Seminars in Immunopathology
- Differential Modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of Host Peripheral Lipid Metabolism and Histone Acetylation in Mouse Gut Organoids
- (2014) S. Lukovac et al. mBio
- The fermentation of polydextrose in the large intestine and its beneficial effects
- (2014) H. Röytiö et al. Beneficial Microbes
- Mycobacterium tuberculosis Exploits Asparagine to Assimilate Nitrogen and Resist Acid Stress during Infection
- (2014) Alexandre Gouzy et al. PLoS Pathogens
- NOD-Like Receptors: Master Regulators of Inflammation and Cancer
- (2014) Mansi Saxena et al. Frontiers in Immunology
- A decrease of the butyrate-producing speciesRoseburia hominisandFaecalibacterium prausnitziidefines dysbiosis in patients with ulcerative colitis
- (2013) Kathleen Machiels et al. GUT
- Whole Genome Gene Expression Meta-Analysis of Inflammatory Bowel Disease Colon Mucosa Demonstrates Lack of Major Differences between Crohn's Disease and Ulcerative Colitis
- (2013) Atle van Beelen Granlund et al. PLoS One
- NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-κB Signaling
- (2012) Irving C. Allen et al. IMMUNITY
- The Mitochondrial Proteins NLRX1 and TUFM Form a Complex that Regulates Type I Interferon and Autophagy
- (2012) Yu Lei et al. IMMUNITY
- Post-transcriptional Inhibition of Luciferase Reporter Assays by the Nod-like Receptor Proteins NLRX1 and NLRC3
- (2012) Arthur Ling et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis
- (2012) Chia-Chou Chu et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κB
- (2012) Monika Schneider et al. NATURE IMMUNOLOGY
- Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
- (2012) Xochitl C Morgan et al. GENOME BIOLOGY
- The role of PARP1 in the DNA damage response and its application in tumor therapy
- (2012) Zhifeng Wang et al. Frontiers of Medicine
- NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK
- (2011) Xiaojun Xia et al. IMMUNITY
- NLRX1 Protein Attenuates Inflammatory Responses to Infection by Interfering with the RIG-I-MAVS and TRAF6-NF-κB Signaling Pathways
- (2011) Irving C. Allen et al. IMMUNITY
- Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers
- (2011) Tingting Wang et al. ISME Journal
- Dietary and nutritional considerations for inflammatory bowel disease
- (2011) Miranda C. E. Lomer PROCEEDINGS OF THE NUTRITION SOCIETY
- Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans
- (2011) B. D. Muegge et al. SCIENCE
- Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila
- (2011) Muriel Derrien et al. Frontiers in Microbiology
- Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria
- (2010) Chin Wen Png et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-κB and JNK pathways by inducing reactive oxygen species production
- (2008) Ivan Tattoli et al. EMBO REPORTS
- Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
- (2008) Dorota Walkiewicz et al. INFLAMMATORY BOWEL DISEASES
- The Arginine Catabolic Mobile Element and Staphylococcal Chromosomal CassettemecLinkage: Convergence of Virulence and Resistance in the USA300 Clone of Methicillin‐ResistantStaphylococcus aureus
- (2008) Binh An Diep et al. JOURNAL OF INFECTIOUS DISEASES
- The Nod-Like Receptor (NLR) Family: A Tale of Similarities and Differences
- (2008) Martina Proell et al. PLoS One
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
- (2008) H. Sokol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now